GENOVA, Inc.

Tokyo Stock Exchange 9341.T

GENOVA, Inc. EBT Margin for the year ending March 31, 2024: 26.97%

GENOVA, Inc. EBT Margin is 26.97% for the year ending March 31, 2024, a 2.25% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • GENOVA, Inc. EBT Margin for the year ending March 31, 2023 was 26.37%, a 19.60% change year over year.
  • GENOVA, Inc. EBT Margin for the year ending March 31, 2022 was 22.05%, a 3.31% change year over year.
  • GENOVA, Inc. EBT Margin for the year ending March 31, 2021 was 21.34%.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Tokyo Stock Exchange: 9341.T

GENOVA, Inc.

CEO Mr. Tomoki Hirase
IPO Date Dec. 23, 2022
Location Japan
Headquarters Shibuya Hikarie
Employees 352
Sector Health Care
Industries
Hospitals & Clinics Medical Instruments Pharmaceuticals Telehealth
Description

GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the clinic; and CLINIC BOT, an AI Chatbot System. The company was founded in 2005 and is headquartered in Tokyo, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email